Answers are grounded in this paper and cite their sources.
To investigate the pharmacokinetics, safety, and tolerability of the novel tetrameric high-relaxivity gadolinium-based contrast agent gadoquatrane in Japanese (Study 1) and Chinese men (Study 2).
No takes yet. Share an insight, caveat, or question.
He et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: